To evaluate pain severity trajectories over 48-hours in subjects treating a single migraine attack with zavegepant 10mg nasal treatment (zavegepant) or placebo.
No takes yet. Share an insight, caveat, or question.
Jayasinghe et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: